CHAPTER 405
S.P. 560 - L.D. 1722
An Act to Recognize Exemplary Efforts to Lower the Cost of Prescription Drugs
Be it enacted by the People of the State of Maine as follows:
Sec. 1. 22 MRSA §254, sub-§8-B is enacted to read:
8-B. Action with regard to nonparticipating manufacturers and labelers. The names of manufacturers and labelers who do and do not enter into rebate agreements pursuant to subsection 8 are public information. The department shall release this information to health care providers and the public on a regular basis and shall publicize participation by manufacturers and labelers that is of particular benefit to the public.
Sec. 2. 22 MRSA §2681, sub-§7, as enacted by PL 1999, c. 786, Pt. A, §3, is amended to read:
7. Action with regard to nonparticipating manufacturers and labelers. The names of manufacturers and labelers who do and do not enter into rebate agreements pursuant to this subchapter are public information. The department shall release this information to health care providers and the public on a regular basis and shall publicize participation by manufacturers and labelers that is of particular benefit to the public. The department shall impose prior authorization requirements in the Medicaid program under this Title, as permitted by law, for the dispensing of prescription drugs provided by those manufacturers and labelers.
Sec. 3. Effective date. This Act takes effect on the date that the Department of Human Services begins offering prescription drug benefits under the Maine Rx Program as defined in the Maine Revised Statutes, Title 22, section 2681.
Effective September 21, 2001, unless otherwise indicated.
| Revisor of Statutes Homepage | Subject Index | Search | Laws of Maine | Maine Legislature |
